Genprex Inc Sustainability Reports
Genprex, Inc. is a clinical-stage gene therapy company focused on developing technologies for patients with cancer and diabetes. The company's pipeline includes its lead product candidate, REQORSA, designed to administer disease-fighting genes in combination with targeted therapies and immunotherapies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300KS9771JZ234890
4 reports from 2020 to 2024
Company Profile
Genprex, Inc. is a clinical-stage gene therapy company focused on developing technologies for patients with cancer and diabetes. The company's pipeline includes its lead product candidate, REQORSA, designed to administer disease-fighting genes in combination with targeted therapies and immunotherapies.
Reports
4 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
